Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management of Suspected Hypertrophic Cardiomyopathy (HCM)
Viz.ai has submitted a de novo classification request to the [...]
Viz.ai has submitted a de novo classification request to the [...]
The Empirical Technologies and Empirical Europe teams are ready to [...]
tDCS devices aren’t a replacement for mental health professionals or [...]
Tyler Binney, President and CEO of Relievant Medsystems. “The ASPN [...]
EvoEndo notes based on information submitted to CMS including the [...]
The new Barostim NEO2 Implantable Pulse Generator launches in the [...]
The release of the Gen II NUVIS features a patent-pending [...]
This new agreement is reinforcing the partnership between Novo Nordisk [...]
Dozee notes their easy-to-use ECG patch augments the company’s current [...]
“A new CPT code is an important milestone for ENT [...]